
Company valuation, historical trends, and peer comparisons.
According to Vaxcyte, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.42B. This represents a change of 37.90% compared to the average of 6.83B of the last 4 quarters.
The mean historical Enterprise Value of Vaxcyte, Inc. over the last ten years is 2.86B. The current 9.42B Enterprise Value has changed 229.48% with respect to the historical average. Over the past ten years (40 quarters), PCVX's Enterprise Value was at its highest in in the September 2024 quarter at 13.11B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
2.86B
Median
1.18B
Minimum
29.27M
Maximum
9.67B
Discovering the peaks and valleys of Vaxcyte, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 886.56%
Maximum Annual Enterprise Value = 9.67B
Minimum Annual Increase = -52.48%
Minimum Annual Enterprise Value = 29.27M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 6.33B | -34.50% |
| 2024 | 9.67B | 68.66% |
| 2023 | 5.73B | 149.90% |
| 2022 | 2.29B | 93.93% |
| 2021 | 1.18B | 196.64% |
| 2020 | 398.81M | 886.56% |
| 2019 | 40.42M | 38.13% |
| 2018 | 29.27M | -52.48% |
The current Enterprise Value of Vaxcyte, Inc. (PCVX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
7.25B
5-year avg
5.04B
10-year avg
2.86B
Vaxcyte, Inc.’s Enterprise Value is greater than Novavax, Inc. (1.70B), greater than Valneva SE (539.31M), less than Pfizer Inc. (235.72B), less than Moderna, Inc. (88.12B), less than GSK plc (94.12B), greater than Vir Biotechnology, Inc. (1.69B), greater than ImmunityBio, Inc. (9.25B), greater than Arcturus Therapeutics Holdings Inc. (111.84M), greater than GeoVax Labs, Inc. (-1104814.00), greater than Evaxion Biotech A/S (11.99M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.70B | $1.59B | |
| 539.31M | $516.79M | |
| 235.72B | $173.50B | |
| 88.12B | $88.56B | |
| 94.12B | $98.61B | |
| 1.69B | $1.87B | |
| 9.25B | $8.52B | |
| 111.84M | $280.39M | |
| -1104814.00 | $1.72M | |
| 11.99M | $18.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxcyte, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vaxcyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vaxcyte, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vaxcyte, Inc. (PCVX)?
What is the 3-year average Enterprise Value for Vaxcyte, Inc. (PCVX)?
What is the 5-year average Enterprise Value for Vaxcyte, Inc. (PCVX)?
How does the current Enterprise Value for Vaxcyte, Inc. (PCVX) compare to its historical average?